A SNP marker composition and a method for diagnosis or prediction of osteochondrodyplasia in cats

The present invention relates to a single nucleotide polymorphic marker composition for predicting or diagnosing cat osteochondrosis, and a predicting or diagnosing method using the same. More specifically, the present invention relates to an SNP marker composition and a method for predicting or dia...

Full description

Saved in:
Bibliographic Details
Main Authors HONG SEUNG BUM, JISUK YOU, KIM YOUNG DEUG, SHIN AE RI, PARK BYEONG JOO, JUNG JIN WOOK
Format Patent
LanguageEnglish
Korean
Published 20.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a single nucleotide polymorphic marker composition for predicting or diagnosing cat osteochondrosis, and a predicting or diagnosing method using the same. More specifically, the present invention relates to an SNP marker composition and a method for predicting or diagnosing cat osteochondrosis, wherein the composition comprises an agent capable of amplifying or detecting single nucleotide polymorphism (SNP) of transient receptor potential cation channel subfamily V, member 4 (TRPV4). 본 발명은 고양이의 골연골이형성증을 예측 또는 진단하기 위한 단일염기다형성(SNP; single nucleotide polymorphims) 마커 조성물 및 방법에 관한 것으로, 더욱 상세하게는 TRPV4(Transient Receptor Potential cation channel, subfamily V, member 4) 유전자의 단일염기다형성(single nucleotide polymorphism, SNP)을 증폭 또는 검출할 수 있는 제제를 포함하는, 고양이의 골연골이형성증을 예측 또는 진단용 SNP 마커 조성물 및 방법에 관한 것이다.
Bibliography:Application Number: KR20190125378